Slimming Cosmetic Composition with Nitogenin and Caffeine
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cosmetic and dermopharmaceutical products are inadequate in effectively reducing subcutaneous fat overloads and cellulite, with existing slimming compositions often lacking targeted and sustained efficacy.
Innovation Solution
A cosmetic or dermopharmaceutical composition combining nitogenin, a cholesterol-like molecule inhibiting HMGCoA synthase and LDL/VLDL lipoproteins receptors, caffeine or theobromine as a xanthic base stimulating glycerol release, and hydroxycitrate, an inhibitor of de novo triglyceride synthesis from glucose in adipocytes, to block adipocytic differentiation and water retention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing slimming compositions use single or dual active substances, then the formulation is simple, but the slimming efficacy is insufficient and lacks sustained action
Solution Approach 1:
The patent combines four different active substances (cholesterol-like molecule, diterpene, N-octanoyl amino acid, and xanthic base) into a single cosmetic composition. Each substance targets a different mechanism of fat metabolism: cholesterol-like molecules inhibit lipid storage, diterpenes activate lipase for fat breakdown, N-octanoyl amino acids enhance glycerol release, and xanthic bases stimulate lipolysis. This multi-component approach creates synergistic effects that provide sustained and enhanced slimming efficacy compared to single or dual substance formulations.
Solution Approach 2:
The invention creates a composite cosmetic formulation integrating multiple bioactive compounds with complementary mechanisms of action. The composition leverages the specific properties of each substance: the membrane-stabilizing effect of cholesterol-like molecules, the enzyme-activating capability of diterpenes, the metabolic enhancement by N-octanoyl amino acids, and the lipolytic stimulation by xanthic bases. This composite approach allows the formulation to address multiple pathways of fat accumulation simultaneously, providing reliable and sustained slimming results.
2Reliability
If existing compositions target only one lipolysis pathway, then the mechanism is simple, but the ability to reduce subcutaneous fat overloads is limited
Solution Approach 1:
The patent segments the fat metabolism process into four distinct target pathways and assigns a specific active substance to each: (1) cholesterol-like molecules target LDL/VLDL endocytosis and triglyceride storage, (2) diterpenes target hormone-sensitive lipase activation, (3) N-octanoyl amino acids target glycerol release mechanisms, and (4) xanthic bases target general lipolysis stimulation. This segmentation allows each component to optimize its action on a specific pathway while collectively addressing the complex process of subcutaneous fat reduction through multiple simultaneous mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves a synergistic slimming action, reducing subcutaneous fat, preventing fat accumulation, and decreasing water retention, while refining body contours and treating cellulite and stretch marks.
Implementation Method 1
nitogenin, a cholesterol-like molecule inhibiting HMGCoA synthase and LDL/VLDL lipoproteins receptors
Implementation Method 2
caffeine or theobromine as a xanthic base stimulating glycerol release
Implementation Method 3
hydroxycitrate, an inhibitor of de novo triglyceride synthesis from glucose in adipocytes
Data Source
AI summary
The invention concerne new slimming cosmetic or dermopharmaceutical compositions containing, in a dermatologically acceptable carrier, an association of at least a cholesterol-like molécule, at least a xanthic base, and at least an inhibitor of the de novo synthesis of triglycérides from the glucose in adipocytes.